All Editorials articles – Page 3
-
BusinessAntibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?
-
OpinionThe heavy appeal of liquid metals
The shiny and dense fluids offer both ancient mystery and future promise
-
OpinionThe end of chemical warfare
With a final push we might see these terrible weapons disappear from the world in our lifetime
-
-
CareersWhen will funders take action on PhD and postdoc conditions?
Campaigns in the UK, Ireland and Canada await announcements
-
OpinionReturning to the moon
It’s been a while, but space agencies are starting to plan their trips back to our satellite, with the goal of building semi-permanent bases
-
OpinionLessons from Lieber
The prosecution of Charles Lieber has had a chilling effect on US researchers, leaving them uncertain about collaboration with overseas programmes
-
-
OpinionBattery materials going up in smoke
We cannot afford to simply throw away, rather than recycle, these valuable resources
-
-
CareersA more reasonable view of workplace adjustments
Normalising giving people what they need to do their jobs well
-
OpinionNursing success – what next for UK science?
Policy prescriptions for research need cross-party support
-
OpinionHolding the keys to a powerful future
Competition to build battery supply chains means supercharging support to attract investment
-
OpinionNuclear wasted
Atomic energy has the potential to reduce our carbon footprint, but the problem of waste is devilishly complex
-
-
OpinionN-heterocyclic carbenes are more than passive spectators
The practical importance of N-heterocyclic carbenes continues to grow
-
OpinionA year of war in Ukraine
The full-scale Russian invasion of Ukraine is now one year old. For Ukraine, the anniversary has been a moment to reaffirm support among its allies and keep the world’s attention on Kyiv as the conflict moves increasingly by increments with no end in sight. For the Kremlin, the moment has been used to justify continuing the war, as a special operation that was supposed to last weeks now runs into its second year. For those who have lived through the war, it’s a reminder of just how much has changed and how much has been lost.
-
CareersMore guidance makes job and university applications fairer
A question-based format helps candidates prioritise what to tell recruiters
-
OpinionA decade on Crispr is already poised to deliver on its promise
Gene editing could transform healthcare but no disease should be forgotten
-
OpinionHow long until papers list an AI as an author?
Artificial intelligence is superior to humans at numerous tasks, but it is still vulnerable to human biases